CRL · Earnings call · 2026Q2T · Full report

Digital Pathology Automation

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. · 2026-08-05 · Importance 34 · Surprise 42

Charles River is investing in an enhanced digital pathology solution with AI-enabled, end-to-end workflows. The company has more than 140 trained pathologists, and management expects the technology to improve internal operating efficiency and accelerate client program timelines. For clients using the fully integrated solution, the stated goal is to remove at least one week from standard pathology timelines. Management characterized AI tools as both an efficiency enabler and a differentiator for regulated validation and safety-assessment work.

Key facts